Dr. Nelson on Why Patients With mCRC are Often Referred to Surgeons First

Video

In Partnership With:

Douglas A. Nelson, MD, discusses why patients with metastatic colorectal cancer are often referred to surgeons before medical oncologists.

Douglas A. Nelson, MD, associate professor in the Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses why patients with metastatic colorectal cancer (mCRC) are often referred to surgeons before medical oncologists.

Patients with undiagnosed mCRC who are admitted to the hospital for anemia, bleeding, or pain could be referred to a surgeon before being seen by a medical oncologist, says Nelson.

In the outpatient setting, gastroenterologists may diagnose a patient with mCRC, says Nelson. However, if the patient develops an obstruction, the gastroenterologist may refer the patient to a surgeon for resection rather than to a medical oncologist.

According to Nelson, this approach is not always optimal. Certain patients should be seen by a medical oncologist prior to a surgeon.

Related Videos
Rita Nanda, MD
Vikram Narayan, MD
Daniel Olson, MD
Vishal Patel, MD, FAAD, FACMS, associate professor, Dermatology, George Washington (GW) School of Medicine & Health Sciences
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS